Selective inhibition of hepatic collagen accumulation in experimental liver fibrosis in rats by a new prolyl 4‐hydroxylase inhibitor
Martin Bickel, Karl‐Heinz Baringhaus, Martin Gerl, Volkmar Günzler, Jiri Kanta, Ludwig Schmidts, Michael Stapf, Georg Tschank, Klaus Weidmann, Ulrich Werner – 30 December 2003 – Fibrosis and cirrhosis of the liver are often the result of chronic liver damage by a variety of different agents. Pathological accumulation of collagen, disruption of the lobular structure, and impaired hepatocellular function frequently lead to systemic involvement and fatal complications.